1

CURRICULUM VITA

George C. Wood

May 2014

*****************************************************************************

EDUCATION

University of IllinoisMedicalCenter, Chicago

B.S. in Pharmacy 1965

M.S. in Pharmacy 1968, majorpharmaceutics,

minorphysical chemistry

Ph.D. in Pharmacy 1971, majorpharmaceutics,

minorphysical chemistry

RESEARCH INTERESTS – Development of targeted delivery parenteral dosage forms (nanomedicines) for clinical trials.Educational assessment of student performance.

ACADEMIC APPOINTMENTS

19701974 Associate Professor and Director of Clinical Programs,

University ofArizonaCollege of Pharmacy, Tucson

19741976 Associate Professor University ofTennessee Center for the Health

Sciences, College of Pharmacy, Dept. Molecular and Quantum Biology

1976-1984 Professor, Department of Drug and MaterialToxicology,

University of Tennessee Center for the Health Sciences
1984-1994Professor, Department of Pharmaceutics,

University of Tennessee, Memphis, The HealthSciencesCenter

1994-PresentProfessor, Department of Pharmaceutical Sciences,

University of Tennessee, HealthSciences Center, Memphis TN

ADMINISTRATIVE APPOINTMENTS (University of Tennessee)

1975-1976Acting Chairman, Department of Molecular and QuantumBiology

1976-1981Chairman, Department of Drug and Material Toxicology

1977-1979Director, Midsouth Poison Center

19791981 Executive Director, Southern Poison Center

1992 - 2000 Associate Director, Parenterals Medications Laboratory

2009-2010 Director of Research, Parenteral Medications Laboratories,

University of Tennessee, HealthScienceCenter

2010-2011 Director of Research, Plough Center for Sterile Drug Delivery Systems,

University of Tennessee, HealthScienceCenter

2001-2005Assistant Dean for Education and Assessment, UT College of Pharmacy

2005-2008Associate Dean for Academic Affairs, UT College of Pharmacy

EDUCATIONAL RESPONSIBILITIES

(instructed pharmacy students 1965-2014, instructed graduate students (over 40 years), practioners from the pharmaceutical industry, regulators and scientists over 30 years)

Courses Taught

University of Arizona Professional Courses

Introductory Pathology I and II

Biopharmaceutics and Pharmacokinetics

Clinical Pharmacy Practice - two courses

Research in Pharmaceutics

University of Tennessee Professional Courses

Drug and Material Toxicology 221-Diseases and Drug Therapy I

Drug and Material Toxicology 312-Diseases and Drug Therapy V

Drug and Material Toxicology 321 - Clinical Toxicology

Pharmaceutics 111 - Pharmaceutical Mathematics

Pharmaceutics 123 & 133 - Pharmaceutical Technology I and II

Pharmaceutics 113 - Physical Pharmacy

Pharmacy Administration 111 - Orientation to Pharmacy

Pharmaceutics 340, Research for Pharmacy Students

Oral Pathology - BIDX 307, Dental Therapeutics, Lecturer

Pharmaceutical Sciences- 212 Parenteral Medications

Pharmaceutical Sciences 240- Research for Pharmacy Students

Pharmaceutical Sciences261, Special Problems in

Pharmaceutical Sciences

Graduate Courses Taught

Drug and Material Toxicology 621 - Principles of Toxicology I

Drug and Material Toxicology 622 - Principles of Toxicology II

Pharmaceutics 912 - Physical-chemical Interpretation of Drug ActionSystems III Polyphasic and Disperse Systems

Pharmaceutics 819 - Drug Metabolism

Pharmaceutics 900 - Pharmaceutics Research

Pharmaceutical Sciences 814 - Parenteral Medications

Pharmaceutical Sciences 818 - Physical-Chemical Interpretation of

Polyphasic and Disperse Drug Systems
Pharmaceutical Sciences 900 - Doctoral Dissertation and Research

Pharmaceutical Sciences 840-703 Drug Stability

Pharmaceutical Sciences 840-701 Educational Design & Delivery
Pharmaceutical Sciences 840-702 Educational Assessment

Pharmaceutical Sciences 831 Preformulation/FormulationPrinciples for

Pharmaceutical Dosage Forms

Postdoctoral Courses

Aseptic Processing of Parenteral Medications

3 h lecture and 20 h laboratory instruction per class, 4-5 times annually

(for over 30 years)

Aseptic Compounding for Pharmacy Technicians

10 h laboratory instruction per class

GRADUATE COMMITTEES

University of Arizona

Larry Dick M.S. 1974

James Chubb M.S. 1974

Melvin Simrin M.S. 1975

Robert Gillies M.S. 1975

University of Tennessee

Charles Cruze Ph.D. 1977

June Joyner Ph.D. 1977

Dimitri Papadimitrou Ph.D. 1978

Robert Pennington M.S. 1979

Lee Murdaugh Ph.D. 1981

Cynthia S. Phillips M.S. 1986

Vijay Vashi M.S. 1987

Russell Rackley Ph.D. 1989

Brian Jones M.S. 1989

Roger BarrettM.S. 1991

Vijay Vashi Ph.D. 1991

Troy McCall Ph.D. 1992

Sandeep NemaPh.D. 1992

Gurmukh ChananaPh.D. 1993

Prasad GullapalliPh.D. 1993

Robbie KiddM.S..1997

Gopal KrishnaPh.D.1996

Reba RobertsPh.D. 1999

Napasinee Aksornkoae Ph.D 2002

Yogita Bahl Ph.D. 2002

Yanli Mi Ph.D. 2002

Ramakrishna Nallamothu, Ph. D 2006

Murali Divi Ph.D. 2007

Hari Desu……………………Ph.D 2009

Vinayagam Kannan Ph.D. 2010

Sonia Bedi, Ph.D. 2011

Elizabeth Barker,Ph. D2014

Nivesh Mittel,Ph.D. Candidate

Bivash Mandal,Ph.DCandidate

Rui Zhu, Ph.D. 2013

Jin Xu Ph.D. 2012

Ningning Yang Ph.D. 2012

Bret Koertge, Ph.D. 2014

Suresh Potaraju Ph.D. 2012

Yinqi Zhou Ph.D. 2012

Pavan Balabathula Ph.D.

Wararat Limothal Ph.D.

Postdoctoral Fellows

Meera Iyer, PhD, 1992 - 1994,

Pruthvipaty Katikaneneni, Ph.D., Jan, 1994 - Dec 1994.

Mustaq Fruitiwala Ph.D. Sept 1994-March 1995

Yixin Chen Ph.D. August 1996-1998

Feng Bei, Ph.D. 1995-1999
Patrick Rodrigues, Ph.D. 1999-2000

Himanshu Bhattacharjee Ph.D. 2007-2009

Extramural Support

Dr. Wood has worked as part of the Plough Center for Sterile Drug Delivery on the development of over $10 million for new drug development projects. Additionally, he helped raise $4,500,000 for the development of the new Plough Center for Sterile Drug Delivery. He has worked on Dept of Defense and NIH projects for the development of innovative drug products for the battlefield, various cancers and and high mortality infectious diseases.

Examples of Publications and Patents

R. Nallamothu, G.Wood, M. Divi, H. Desu, F. Horton, L. Thoma "A Tumor Vasculature Targeted Liposome Delivery System for CombretastatinA4:Design, Characterization and In Vitro AAPS PharmSciTech, 2006.

Duntsch C, Divi M K, Jones T, Zhou Q, Krishnamurthy M, Boehm P, Wood G, Sills A, Moore B M, Safety and efficacy of novel cannabinoid chemotherapeutic KM-233 for the treatment of high grade glioma, J Neurooncol 2006, April 77(2): 143-152

Scott, R.C., Want B. Nallamothu, R, Pattillo C, Perez-Liz G, Issekutz A, Dell Valle L, Wood, G.C., Kiani M F,, Targeted delivery of antibody conjugated liposome delivery system for combretastatin A4: design characterization and in vitro evaluation, Biotechnol Bioeng 2007 April 7;7(2):E32

Targeted nanoparticulate drug-delivery systems for treatment of solid tumors: a review

Bhattacharjee, Himanshu; Balabathula, Pavan; Wood, George C.;Therapeutic Delivery (2010), 1(5), 713-734.

Principles of Pharmaceutics in Dosage Form Design. Himanshu Bhattacharjee and George C. Wood; APhA Complete Review for the FPGEE® : Foreign Pharmacy Graduate Equivalency Examination®; Edited by Dick R. Gourley ; ISBN: 1582121435, Publish Date: August 1st 2010

Hongkee Sah, Laura A. Thoma, Hari R. Desu, Edel Sah, and George C. Wood. “Concepts and practices used to develop functional PLGA-based nanoparticulate systems”International Journal of Nanomedicine 2013:8 747-65

Mandal B,Balabathula P,Mittal N,Wood GC,Bhattacharjee H. Development and validation of a spectrofluorimetric method for the determination of erlotinib in spiked human plasma. J Fluoresc.2012 Nov; 22(6):1425-9. doi: 10.1007/s10895-012-1103-8. Epub 2012 Aug 9.

Bivash Mandal, Himanshu Bhattacharjee, Nivesh Mittal, Hongkee Sah, Pavan Balabathula, Laura A. Thoma,George C. Wood. “Core-Shell Type Lipid-Polymer Hybrid Nanoparticles as Drug Delivery Platform. Nanomedicine: Nanotechnology, Biology and Medicine 2013; May 2013, Vol.9, Issue 4, pages 474-491 Top journal in our area of research on nanoparticle drugs.

Nivesh Mittal, Himanshu Bhattacharjee, Bivash Mandal, Pavan Balabathula, Laura Thoma, George C. Wood, “Targeted liposomal drug delivery systems for the treatment of B cell malignancies:, Journal of Drug Targeting, 0, 1-15, Online January 16, 2014

P. Balabathula, D. R. Janagam, N.K. Mittal, B. Mandal, L. Thoma, G. C. Wood, Rapid quantitative evaluation of Amphotericin B in Human Plasma by a validated HPLC Method, Journal of Bioequivalence and Bioavailability, 5, 121-1124, 2013.

Patent 2014, U.S. Provisional Patent No. 61/874,646 for “Liposomes for hematological tumors” Nivesh K. Mittal, George C. Wood, Leonard Lothstein, Pavan Balabathula, Bivesh Mandal

Examples of Abstracts/Presentations

P, Balabathula, S. G Whaley, N. K Mittal, B. Mandal, L. A. Thoma, D.P. Rogers. G. C. Wood, Multifunctional Iron Oxide Nanoparticles for Imaging and Therapy of Systemic Fungal Infections. American Association of Pharmaceutical Scientists, Annual Meeting, San Antonio, TX, 2013.

B Mandal, N. Mittal, P. Balabathula, L. A. Thoma, G. C. Wood. Development and Evaluation of Phospholipid coated Albumin Nanoparticles for the Delivery of Erlotinib in Non-Small Cell Lung Cancer, American Association of Pharmaceutical Scientists, Annual Meeting, San Antonio, TX, 2013.

N. K . Mittal, B. Mandal, P. Balabathula, L. Lothstein, L. A. Thoma, G. C. Wood, Formulation of AD198 Liposomes. American Association of Pharmaceutical Scientists, Annual Meeting, San Antonio, TX, 2013.